Key points
- The Florey’s first impact report, Life-changing discoveries, was launched on Wednesday 22 May 2024 at the Ian Potter Auditorium in Parkville.
- The event included speakers who have lived experience of the conditions Florey researchers have dedicated their work into studying.
The report highlights our work in advancing research to find cures and treatments to help people who live with neurological and mental health conditions, and includes the stories of:
- Sepsis survivor Mandy McCracken, who is keenly following Florey research into a treatment for sepsis
- ‘John’, who has MND and shares his experience of diagnosis and the peace of mind he felt after connecting with The Florey
- Suzanne Baxter, who is part of a clinical trial into the revolutionary Alzheimer’s drug lecanemab
- Brianna Magdalani, who survived a stroke and has benefited from the Young Stroke Service at The Florey
- Anthony Becker, the first person in the world to have a device implanted to counter his Crohn’s disease.
As part of the event, we heard directly from families and individuals living with motor neurone disease, epilepsy and other complex illnesses, joined by leading scientists who have dedicated their work into studying and tackling these conditions.
You can watch a recording of the launch below.
